Monday morning was a dull one at Wave Life Sciences (NASDAQ:WVE). This was because the company’s shares declined by 50%. About the flop Analysts attribute this major drop to the recent discontinuation of the company’s suvodirsen. It was a product under development to help patients struggling with a condition known as Duchenne muscular dystrophy. DMD […]
Sign Up To Get Our Instant Alerts!
- Japanese Premier Declares COVID-19 State of Emergency in Tokyo 117 views
- Buscar Company has completed the acquisition of APTG Inc., a Solar Concentrated Power technology company 75 views
- Google Gives Spotify its Own In-App Payment Option as Part of a New Pilot 66 views
- Toyota Suspends Production at 2 Plants in Japan Citing Chip Shortage 64 views
- China Unveils Maglev Train With a Top Speed of 600 kph 50 views